transformation pathways
Recently Published Documents


TOTAL DOCUMENTS

239
(FIVE YEARS 99)

H-INDEX

32
(FIVE YEARS 8)

2022 ◽  
Vol 160 ◽  
pp. 107055
Author(s):  
Susanne Waaijers-van der Loop ◽  
Anne van Bruggen ◽  
Nick R.M. Beijer ◽  
Adrienne Sips ◽  
Ana Maria de Roda Husman ◽  
...  

Author(s):  
Yingzi Lin ◽  
Mingliang Zhou ◽  
Gaoqi Wang ◽  
Hao Li ◽  
Yuhang Wei ◽  
...  

2021 ◽  
Vol 44 ◽  
pp. 102324
Author(s):  
Jinxin Lu ◽  
Jiaqi Li ◽  
Jianye Xu ◽  
Huili Tang ◽  
Zhen Lv ◽  
...  

Author(s):  
Yusha Yang ◽  
Yang Li ◽  
Chaoran Luan ◽  
Nelson Rowell ◽  
Shanling Wang ◽  
...  

2021 ◽  
Author(s):  
Yusha Yang ◽  
Yang Li ◽  
Chaoran Luan ◽  
Nelson Rowell ◽  
Shanling Wang ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Pei Tao ◽  
Yan Wang ◽  
Yujie Wang

To ensure safety and efficacy, most Aconitum herbs should be processed before clinical application. The processing methods include boiling, steaming, and sand frying. Among these methods, the transformation pathways of diterpenoid alkaloids in the process of sand frying are more complicated. Therefore, crassicauline A, a natural product with two ester bonds, was chosen as the experimental object. Consequently, a known alkaloid, together with three new alkaloids, was derived from crassicauline A. Meanwhile, the cardiotoxicity of converted products was reduced compared with their parent compound. Interestingly, some diterpenoid alkaloids have similar structures but opposite effects, such as arrhythmia and antiarrhythmic. Considering the converted products are structural analogues of crassicauline A, herein, the antiarrhythmic activity of the transformed products was further investigated. In a rat aconitine-induced arrhythmia assay, the three transformed products, which could dose-dependently delay the ventricular premature beat (VPB) incubation period, reduce the incidence of ventricular tachycardia (VT), combined with the increasing arrhythmia inhibition rate, exhibited prominent antiarrhythmic activities. Our experiments speculated that there might be at least two transformation pathways of crassicauline A during sand frying. The structure-activity data established in this paper constructs the critical pharmacophore of diterpenoid alkaloids as antiarrhythmic agents, which could be helpful in searching for the potential drugs that are equal or more active and with lower toxicity, than currently clinical used antiarrhythmic drugs.


2021 ◽  
Vol 14 (10) ◽  
pp. 6571-6603
Author(s):  
Lavinia Baumstark ◽  
Nico Bauer ◽  
Falk Benke ◽  
Christoph Bertram ◽  
Stephen Bi ◽  
...  

Abstract. This paper presents the new and now open-source version 2.1 of the REgional Model of INvestments and Development (REMIND). REMIND, as an integrated assessment model (IAM), provides an integrated view of the global energy–economy–emissions system and explores self-consistent transformation pathways. It describes a broad range of possible futures and their relation to technical and socio-economic developments as well as policy choices. REMIND is a multiregional model incorporating the economy and a detailed representation of the energy sector implemented in the General Algebraic Modeling System (GAMS). It uses non-linear optimization to derive welfare-optimal regional transformation pathways of the energy-economic system subject to climate and sustainability constraints for the time horizon from 2005 to 2100. The resulting solution corresponds to the decentralized market outcome under the assumptions of perfect foresight of agents and internalization of external effects. REMIND enables the analyses of technology options and policy approaches for climate change mitigation with particular strength in representing the scale-up of new technologies, including renewables and their integration in power markets. The REMIND code is organized into modules that gather code relevant for specific topics. Interaction between different modules is made explicit via clearly defined sets of input and output variables. Each module can be represented by different realizations, enabling flexible configuration and extension. The spatial resolution of REMIND is flexible and depends on the resolution of the input data. Thus, the framework can be used for a variety of applications in a customized form, balancing requirements for detail and overall runtime and complexity.


2021 ◽  
Vol 119 (17) ◽  
pp. 171905
Author(s):  
Kamalnath Kadirvel ◽  
Zachary Kloenne ◽  
Jacob K. Jensen ◽  
Hamish Fraser ◽  
Yunzhi Wang

2021 ◽  
Vol 2021 ◽  
pp. 1-12
Author(s):  
Yu-Jie Wang ◽  
Pei Tao ◽  
Yan Wang

The transformation pathways of diterpenoid alkaloids have been clarified in the boiling and steaming process. Aconitine, a famous diterpenoid alkaloid, is successively transformed into benzoylaconine and aconine during the processes of boiling and steaming, but the transformation pathway remains to be determined in the sand frying process. The present study aims at investigating the transformation pathways of aconitine in the process of sand frying, as well as assessing the cardiotoxicity and antiarrhythmic activity of aconitine and its converted products. The parameters of temperature and time for the structural transformation of aconitine were confirmed by HPLC. The converted products were further separated and identified by column chromatography, NMR, and HR-ESI-MS. Furthermore, by observing the lead II electrocardiogram (ECG) changes in rats under an equivalent dose, the cardiotoxicity of aconitine and its converted products were compared. Ultimately, the antiarrhythmic effect of the converted products was investigated by employing the model of aconitine-induced arrhythmia. Consequently, the structure of aconitine was converted when processed at 120°C–200°C for 1–40 min. Two diterpenoid alkaloids, a pair of epimers, namely, pyroaconitine and 16-epi-pyroaconitine, were further isolated from processed aconitine. 0.03 mg/kg aconitine induced arrhythmias in normal rats, while the converted products did not exhibit arrhythmias under an equal dose. In the antiarrhythmic assay, 16-epi-pyroaconitine could dose-dependently delay the onset time of VPB, reduce the incidence of VT, and increase the arrhythmia inhibition rate, demonstrating comparatively strong antiarrhythmic activity. Conclusively, compared with the prototype compound aconitine, the converted products exhibited lower cardiotoxicity. Further investigations on the cardiotoxicity indicated that pyroaconitine with β configuration had a stronger cardiotoxicity than 16-epi-pyroaconitine with α configuration. Furthermore, 16-epi-pyroaconitine could antagonize the arrhythmogenic effect caused by the prototype compound aconitine; the antiarrhythmic effect of 16-epi-pyroaconitine was stronger than lidocaine and propafenone, which had the potential to be developed as antiarrhythmic drugs.


Sign in / Sign up

Export Citation Format

Share Document